HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway.

Abstract
A study was performed in order to determine the prevalence of anti-hepatitis C virus (HCV) antibodies, the risk factors for HCV infection and the markers of hepatic disease in a population of prisoners. Of 101 new prisoners admitted to a Norwegian national prison over a three month period, 70 were included in the study, of whom 32 (46%) were anti-HCV positive. Intravenous drug abuse was the predominant risk factor for HCV infection, although a history of tattooing was found by logistic regression analysis to be a significant risk factor independent of intravenous drug abuse. Most anti-HCV positive prisoners had a history of previous incarcerations. Among the anti-HCV positive subjects, increased alanine aminotransferase (> 50 U/l) was found in 23 (72%). HCV infection was the major cause of hepatic abnormalities in the study population. Only 15 (47%) of the anti-HCV positive prisoners reported knowledge of previous hepatic disease.
AuthorsD S Holsen, S Harthug, H Myrmel
JournalEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (Eur J Clin Microbiol Infect Dis) Vol. 12 Issue 9 Pg. 673-6 (Sep 1993) ISSN: 0934-9723 [Print] Germany
PMID7694850 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hepatitis Antibodies
  • Hepatitis C Antibodies
  • Alanine Transaminase
Topics
  • Adolescent
  • Adult
  • Alanine Transaminase (blood)
  • Analysis of Variance
  • Female
  • Hepacivirus (immunology)
  • Hepatitis Antibodies (blood)
  • Hepatitis C (epidemiology, transmission)
  • Hepatitis C Antibodies
  • Humans
  • Male
  • Middle Aged
  • Norway (epidemiology)
  • Prisoners
  • Regression Analysis
  • Risk Factors
  • Substance Abuse, Intravenous (complications)
  • Tattooing (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: